State-of-the-Art Diagnostics We use advanced analysis tools such as Vectra 3D scanning, InBody body composition analyzer, and ShapeScale technology to get data-driven insights about your body
In the SURMOUNT-1 trial, roughly 30 percent of patients at the highest dose reported nausea at some point, but the majority described it as mild to moderate, and discontinuation rates due to nausea were relatively low
The reasons are multifactorial: chronic inflammation damages blood vessel walls, corticosteroid use raises cholesterol and blood pressure, lupus-specific antibodies (particularly antiphospholipid antibodies) increase clotting risk, and the metabolic disruption caused by both the disease and its treatments creates a perfect storm for atherosclerosis
Not for human or animal consumption, not a drug, food, cosmetic, or supplement